drugset / Trial / NCT01606176

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

NCT01606176

Phase 3 Completed 70 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate the ability of a cannabis based medicine extract to relieve chronic refractory pain of neurological origin.

Timeline

Start
2002-03
Primary completion
2002-08
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified

Indications